Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral naproxen, ketorolac, or ibuprofen before inferior alveolar nerve block for symptomatic irreversible pulpitis
IRCT20181021041405N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naproxen, ketorolac and ibuprofen in irreversible pulpitis (4 arms), sponsored by Islamic Azad University. Primary endpoint: Pain severity. Started Dec 2018; status: completed.
02
Drugs
naproxenketorolacibuprofen
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20181021041405N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181021041405N1.